3D microtumors in vitro supported by perfused vascular networks
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors and stromal cells (endothelial cells) coexisted in these microvessels networks for up to 24 days.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tumors grew vigorously in the 3D extracellular matrix, depending for survival entirely on nutrient delivery through living, fully functional, and leak-free vasculature.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Remarkably, HCT116-cells growing in the vascularized microfluidic tumors exhibited chemoresistance to oxaliplatin that was one order higher than that shown by cells cultured in a 2D monolayer.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Specifically, this model allows for the creation of “vascularized micro-tumors” (VMTs), whereby the coculture of endothelial colony-forming cell-derived ECs, normal human lung fibroblasts and cancer cells under dynamic flow conditions enables the de novo formation of perfusable microvascular networks that surround the micro-tumors, supplying nutrients and therapeutics just as tumor-associated”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Sobrino et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The authors recreated, in a geometrically simple device (Figure 7e-i), a fully perfusable and complex vasculature network and was able to demonstrate the feasibility of culturing tumor spheroids for extended time periods.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Cited by
Items 101–200 of 388
Uwamori, H., Ono, Y., Yamashita, T., Arai, K., & Sudo, R. (2019) · Microvascular Research · doi:10.1016/j.mvr.2018.11.007 · Cited by 57
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Franchi-Mendes, T., Eduardo, R., Domenici, G., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13184610 · Cited by 68
Engineering next generation vascularized organoids
Werschler, N., Quintard, C., Nguyen, S., & Penninger, J. M. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118529 · Cited by 69
Metabolic fingerprinting of bacteria by fluorescence lifetime imaging microscopy
Bhattacharjee, A., Datta, R., Gratton, E., & Hochbaum, A. I. (2017) · Scientific Reports · doi:10.1038/s41598-017-04032-w · Cited by 67
Self-citationParrish, J., Lim, K. S., Baer, K., Hooper, G. J., & Woodfield, T. B. F. (2018) · Lab on a Chip · doi:10.1039/c8lc00485d · Cited by 61
Organ-on-a-chip technology: turning its potential for clinical benefit into reality
Haddrick, M., & Simpson, P. B. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.011 · Cited by 63
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics
Advani, D., Sharma, S., Kumari, S., Ambasta, R. K., & Kumar, P. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210308101029 · Cited by 71
Driver, R., & Mishra, S. (2022) · BioChip Journal · doi:10.1007/s13206-022-00087-8 · Cited by 69
“Sobrino [40] developed in-vitro vascularized micro tumours (VMTs) on a microfluidic device.”
MethodHormuth, D. A., Phillips, C. M., Wu, C., Lima, E. A. B. F., Lorenzo, G., Jha, P. K., Jarrett, A. M., Oden, J. T., & Yankeelov, T. E. (2021) · Cancers · doi:10.3390/cancers13123008 · Cited by 71
“Many microfluidic devices are widely reproducible and allow for a systematic investigation of vasculogenesis [110–113], angiogenesis [114–117], and response to antiangiogenic therapies [118].”
BackgroundKutys, M. L., Polacheck, W. J., Welch, M., Gagnon, K. A., Koorman, T., Kim, S., Li, L., McClatchey, A. I., & Chen, C. S. (2020) · Nature Communications · doi:10.1038/s41467-020-17102-x · Cited by 60
Microphysiological Systems (“Organs‐on‐Chips”) for Drug Efficacy and Toxicity Testing
Low, L., & Tagle, D. (2017) · Clinical and Translational Science · doi:10.1111/cts.12444 · Cited by 53
Bourn, M. D., Batchelor, D. V. B., Ingram, N., McLaughlan, J. R., Coletta, P. L., Evans, S. D., & Peyman, S. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.011 · Cited by 57
Microfluidic modeling of the biophysical microenvironment in tumor cell invasion
Huang, Y. L., Segall, J. E., & Wu, M. (2017) · Lab on a Chip · doi:10.1039/c7lc00623c · Cited by 54
Kim, H. N., Habbit, N. L., Su, C., Choi, N., Ahn, E. H., Lipke, E. A., & Kim, D. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807553 · Cited by 57
Design of an Integrated Microvascularized Human Skin-on-a-Chip Tissue Equivalent Model
Jones, C. F. E., Ciò, S. D., Connelly, J. T., & Gautrot, J. E. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.915702 · Cited by 57
“Another attractive alternative proposed consists in placing spheroids, and in some cases organoids within wells designed within the hydrogel compartment, therefore enabling the vascularization of resulting tissue models (Homan et al., 2019, Ko et al., 2019a, Shin et al., 2021, Sobrino et al., 2016).”
BackgroundSimitian, G. S., Virumbrales-Muñoz, M., Sánchez‐de‐Diego, C., Beebe, D. J., & Kosoff, D. (2022) · Lab on a Chip · doi:10.1039/d2lc00352j · Cited by 56
Vascularized human brain organoid on-chip
Tan, S. Y., Feng, X., Cheng, L. K., & Wu, A. R. (2023) · Lab on a Chip · doi:10.1039/d2lc01109c · Cited by 64
Rothbauer, M., Bachmann, B., Eilenberger, C., Kratz, S. R. A., Spitz, S., Höll, G., & Ertl, P. (2021) · Micromachines · doi:10.3390/mi12050470 · Cited by 55
“established micro-vasculatures on a 96-well plate format [165] to independently perfuse microvascular organoids by hydrostatic pressure based on their 3D micro-tumor biochip design [166].”
MethodRapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model
Vu, M. N., Rajasekhar, P., Poole, D. P., Khor, S. Y., Truong, N. P., Nowell, C. J., Quinn, J. F., Whittaker, M., Veldhuis, N. A., & Davis, T. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b02056 · Cited by 52
Cardiovascular Effects of Polychlorinated Biphenyls and Their Major Metabolites
Grimm, F. A., Klaren, W. D., Li, X., Lehmler, H., Karmakar, M., Robertson, L. W., Chiu, W. A., & Rusyn, I. (2020) · Environmental Health Perspectives · doi:10.1289/ehp7030 · Cited by 53
“In this respect, the use of the microphysiological systems for both heart (Mathur et al. 2015) and the vasculature (Sobrino et al. 2016) promises to narrow this gap and o ff er enhanced physiological relevance.”
A 3D human adipose tissue model within a microfluidic device
Yang, F., Carmona, A., Stojkova, K., Huitron, E. I. G., GODDI, A. A., Bhushan, A., Cohen, R., & Brey, E. M. (2020) · Lab on a Chip · doi:10.1039/d0lc00981d · Cited by 54
Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs
van den Brand, D., Massuger, L. F., Brock, R., & Verdurmen, W. P. R. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00699 · Cited by 48
Engineering New Microvascular Networks On‐Chip: Ingredients, Assembly, and Best Practices
Tronolone, J. J., & Jain, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202007199 · Cited by 50
Liu, Y., Sakolish, C., Chen, Z., Phan, D. T. T., Bender, R. H. F., Hughes, C. C. W., & Rusyn, I. (2020) · Toxicology · doi:10.1016/j.tox.2020.152601 · Cited by 49
Self-citationWang, J., Wang, H., Wang, Y., Liu, Z., Li, Z., Li, J., Chen, Q., Meng, Q., Shu, W., Wu, J., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.01.055 · Cited by 50
Linear Combination Properties of the Phasor Space in Fluorescence Imaging
Torrado, B., Malacrida, L. S., & Ranjit, S. (2022) · Sensors · doi:10.3390/s22030999 · Cited by 46
Bachmann, B., Spitz, S., Rothbauer, M., Jordan, C., Purtscher, M., Zirath, H., Schuller, P., Eilenberger, C., Ali, S. F., Mühleder, S., et al. (2018) · Biomicrofluidics · doi:10.1063/1.5027054 · Cited by 54
Rambøl, M. H., Han, E. X., & Niklason, L. E. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2019.0186 · Cited by 48
“Sobrino et al.(64) successfully generated perfused tumor spheroids by incorporating tumor cells into microphysiological system containing a perfused microvessel network.”
MethodMuttenthaler, L., & Hebart, M. N. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2021.679838 · Cited by 67
In vitro fluidic systems: Applying shear stress on endothelial cells
Meng, F., Cheng, H., Qian, J., Dai, X., Huang, Y., & Fan, Y. (2022) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2022.100143 · Cited by 58
Microphysiological systems for recapitulating physiology and function of blood-brain barrier
Seo, S., Kim, H., Sung, J. H., Choi, N., Lee, K., & Kim, H. N. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119732 · Cited by 47
“growth dynamics, and marker expression [193,195,208].”
Tan, S. Y., Leung, Z., & Wu, A. R. (2020) · Small · doi:10.1002/smll.201905055 · Cited by 49
Engineering Breast Cancer On-chip—Moving Toward Subtype Specific Models
Moccia, C., & Haase, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.694218 · Cited by 51
“…formed perfusable microvessels by seeding combinations of endothelial cells and fibroblasts embedded in hydrogels together with tumoral cells (Sobrino et al., 2016; Agarwal et al., 2017; Chung et al., 2017; Mannino et al., 2017; Nashimoto et al., 2017; Tang et al., 2017; Song et al., 2018;…”
BackgroundDevelopmental angiocrine diversification of endothelial cells for organotypic regeneration
Gómez-Salinero, J. M., Itkin, T., & Rafii, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.020 · Cited by 50
Bender, R. H. F., O’Donnell, B. T., Shergill, B. S., Pham, B. Q., Tahmouresie, S., Sanchez, C. N., Juat, D. J., Hatch, M. M. S., Shirure, V. S., Wortham, M., et al. (2023) · Biofabrication · doi:10.1088/1758-5090/ad17d0 · Cited by 49
“As we have noted before [26, 33] a proportion of the stromal cells we add can differentiate into pericytes, and we see that also in the islet-VMO (figures 1(D) and (E)).”
BackgroundMethodSelf-citationHigh‐Scale 3D‐Bioprinting Platform for the Automated Production of Vascularized Organs‐on‐a‐Chip
Fritschen, A., Lindner, N., Scholpp, S., Richthof, P., Dietz, J., Linke, P., Guttenberg, Z., & Blaeser, A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304028 · Cited by 44
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Microvascular bioengineering: a focus on pericytes
Zhao, H., & Chappell, J. C. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0158-3 · Cited by 49
New Frontiers for Biofabrication and Bioreactor Design in Microphysiological System Development
Parrish, J., Lim, K. S., Zhang, B., Radisic, M., & Woodfield, T. B. F. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.04.009 · Cited by 47
On-chip recapitulation of the tumor microenvironment: A decade of progress
Giannitelli, S. M., Peluzzi, V., Raniolo, S., Roscilli, G., Trombetta, M., Mozetic, P., & Rainer, A. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122482 · Cited by 45
LaBonia, G. J., Ludwig, K. R., Mousseau, C. B., & Hummon, A. B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04969 · Cited by 42
Li, Q., Niu, K., Wang, D., Xuan, L., & Wang, X. (2022) · Lab on a Chip · doi:10.1039/d1lc00767j · Cited by 43
Self-citationReynolds, D. S., de Lázaro, I., Blache, M. L., Liu, Y., Jeffreys, N. C., Doolittle, R. M., Grandidier, E., Olszewski, J. D., Dacus, M. T., Mooney, D. J., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210748 · Cited by 45
Intestine-to-neuronal signaling alters risk-taking behaviors in food-deprived Caenorhabditis elegans
Matty, M. A., Lau, H. E., Singh, A., Haley, J. A., Chakraborty, A., Kono, K., Reddy, K. C., Hansen, M., & Chalasani, S. H. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010178 · Cited by 44
The vascular niche in next generation microphysiological systems
Ewald, M. L., Chen, Y.-H., Lee, A. P., & Hughes, C. C. W. (2021) · Lab on a Chip · doi:10.1039/d1lc00530h · Cited by 43
Self-citationBiomaterial-assisted organoid technology for disease modeling and drug screening
Shao, Y., Wang, J., Jin, A., Jiang, S., Lei, L., & Liu, L. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101438 · Cited by 49
Cancer metabolism gets physical
DelNero, P., Hopkins, B. D., Cantley, L. C., & Fischbach, C. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1011 · Cited by 39
“For example, a vascularized microtumor (VMT) model was used to map metabolic activity within different regions of hybrid microfluidic organoids via fluorescence lifetime imaging of NAD+ (nicotinamide adenine dinucleotide) and NADH (reduced form of NAD+) (40).”
BackgroundMethodTissue‐Engineered Microvessels: A Review of Current Engineering Strategies and Applications
Zhao, N., Pessell, A. F., Zhu, N., & Searson, P. C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303419 · Cited by 43
Vascularized organoid-on-a-chip: design, imaging, and analysis
Yu, T., Yang, Q., Peng, B., Gu, Z., & Zhu, D. Y. (2024) · Angiogenesis · doi:10.1007/s10456-024-09905-z · Cited by 37
“2c, the capillary burst valve design is primarily employed in tissue chamber chips, serving to connect the central chamber with the culture medium channels on both sides [42].”
Microfluidic applications on circulating tumor cell isolation and biomimicking of cancer metastasis
Xu, X., Jiang, Z., Wang, J., Ren, Y., & Wu, A. (2020) · Electrophoresis · doi:10.1002/elps.201900402 · Cited by 38
Optimization of Co-Culture Conditions for a Human Vascularized Adipose Tissue Model
Yang, F., Cohen, R., & Brey, E. M. (2020) · Bioengineering · doi:10.3390/bioengineering7030114 · Cited by 39
“This design strategy has been shown to enable control over mass transport in 3D culture [26,28], and has been used to develop different microfluidic models, including microvascular networks [29,30], the blood–brain barrier [31], microtumors [32], and cancer cell extravasation [33].”
MethodHuman Endothelial Colony-Forming Cells
Melero‐Martin, J. M. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041154 · Cited by 42
“In addition, they respond to angiogenic stimuli by extending lumenized sprouts (Sobrino et al. 2016; Wang et al. 2020).”
BackgroundNgo, M. T., Sarkaria, J. N., & Harley, B. A. C. (2022) · Advanced Science · doi:10.1002/advs.202201888 · Cited by 41
Luque‐González, M. A., Reis, R. L., Kundu, S. C., & Caballero, D. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000045 · Cited by 36
Nguyen, N., Thurgood, P., Sekar, N. C., Chen, S., Pirogova, E., Peter, K., Baratchi, S., & Khoshmanesh, K. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00815-8 · Cited by 39
Son, J., Hong, S. J., Lim, J. W., Jeong, W., Jeong, J. H., & Kang, H. (2021) · Small Methods · doi:10.1002/smtd.202100632 · Cited by 37
Zingales, V., Esposito, M. R., Torriero, N., Taroncher, M., Cimetta, E., & Ruiz, M.-J. (2023) · Toxins · doi:10.3390/toxins15070422 · Cited by 40
Organoid-on-a-chip: Current challenges, trends, and future scope toward medicine
Li, Z., Li, Q., Zhou, C., Lu, K., Liu, Y., Xuan, L., & Wang, X. (2023) · Biomicrofluidics · doi:10.1063/5.0171350 · Cited by 36
Self-citationImaging 3D cell cultures with optical microscopy
Hsieh, H.-C., Han, Q., Brenes, D., Bishop, K. W., Wang, R., Wang, Y., Poudel, C., Glaser, A. K., Freedman, B., Vaughan, J. C., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02647-w · Cited by 49
“Engineered structures such as microfluidic channels can partially mimic the spatial organization of blood vessels and tumors, allowing researchers to study the process of angiogenic sprouting 194–199 .”
Engineering tissue‐specific blood vessels
Herron, L. A., Hansen, C. S., & Abaci, H. E. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10139 · Cited by 35
“A landmark perfusable in vitro vascularized tumor model was established in Sobrino et al.(90) Using a microfluidic platform and seeding it with ECs and ECM, vessel fragments formed in the first 2–3 days and a complete network was visible around Days 5–7.”
MethodLow, L. A., Sutherland, M. L., Lumelsky, N. L., Selimović, Š., Lundberg, M. S., & Tagle, D. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_3 · Cited by 37
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
Advances in Modeling the Immune Microenvironment of Colorectal Cancer
Yoon, P., Piccolo, N. D., Shirure, V. S., Peng, Y., Kirane, A., Canter, R. J., Fields, R. C., George, S. C., & Gholami, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614300 · Cited by 35
“Our group has also pioneered methods to vascularize tissues, including CRC, in OOC devices (39, 103, 106, 113, 121, 122).”
MethodSelf-citationWu, Y., Zhou, Y., Qin, X., & Liu, Y. (2021) · Biomicrofluidics · doi:10.1063/5.0062697 · Cited by 38
Organ-on-Chip platforms to study tumor evolution and chemosensitivity
Dsouza, V. L., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188717 · Cited by 39
Ngo, M. T., Karvelis, E., & Harley, B. A. C. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa010 · Cited by 38
Hachey, S. J., Sobrino, A., Lee, J. G., Jafari, M. D., Klempner, S. J., Puttock, E. J., Edwards, R. A., Lowengrub, J. S., Waterman, M. L., Zell, J. A., et al. (2022) · Translational research · doi:10.1016/j.trsl.2022.11.011 · Cited by 35
“We find that the pVMT supports the growth of a high-grade tubulovillous adenoma (P36), which retains the histology of the parental polyp and demonstrates a top-down metabolic tissue pattern resembling an in vivo crypt 17 as it grows within the pVMT. Stem cells at the base of intestinal crypts have been found to be hig…”
MethodInfluentialSelf-citationBeyond organoids: In vitro vasculogenesis and angiogenesis using cells from mammals and zebrafish
Ibrahim, M., & Richardson, M. K. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.07.002 · Cited by 33
“These tumor-like structures showed reduced growth, and sometimes even regression occurred,in response to standard vascular targeting therapies infused via the microvessels[243].”
BackgroundPhysiomimetic Models of Adenomyosis
Gnecco, J. S., Brown, A. T., Kan, E. L., Baugh, L. M., Ives, C., Loring, M., & Griffith, L. G. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1719084 · Cited by 34
Kim, S., Ko, J., Lee, B., Park, D., Park, S., & Jeon, N. L. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27765 · Cited by 32
Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models
Too, N. S. H., Ho, N. C. W., Adine, C., Iyer, N. G., & Fong, E. L. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.001 · Cited by 35
Stem cell-based vascularization of microphysiological systems
Browne, S., Gill, E., Schultheiss, P. J., Goswami, I., & Healy, K. E. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.015 · Cited by 34
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
Tan, M. L., Lu, L., & Fischbach, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113852 · Cited by 32
Park, J., Kim, S., Hong, J., & Jeon, J. S. (2022) · Lab on a Chip · doi:10.1039/d2lc00597b · Cited by 33
Wang, R., Zhang, C., Li, D., & Yao, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1057913 · Cited by 33
“…response of colorectal and breast cancer cells to vascular targeting agents Provides a model for in vitro studies of vascularized solid tumors Sobrino et al. (2016) Soft lithography Fibrin gels; Endothelial cells (ECs), mesenchymal stem cells and osteoblastic differentiated cells (OBs) Study…”
BackgroundEngineering Mesoscopic 3D Tumor Models with a Self‐Organizing Vascularized Matrix
Lorenzi, F. D., Hansen, N., Theek, B., Daware, R., Motta, A., Breuel, S., Nasehi, R., Baumeister, J., Schöneberg, J., Stojanovic, N. M., et al. (2023) · Advanced Materials · doi:10.1002/adma.202303196 · Cited by 43
Imaging microphysiological systems: a review
Peel, S. E., & Jackman, M. J. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00186.2020 · Cited by 34
Engineered models of tumor metastasis with immune cell contributions
Graney, P. L., Tavakol, D. N., Chramiec, A. G., Ronaldson-Bouchard, K., & Vunjak‐Novakovic, G. (2021) · iScience · doi:10.1016/j.isci.2021.102179 · Cited by 33
“Perfusion allows recreating in vitro stable and functional vascular networks that are capable of supportingmicro-tumors (Sobrino et al., 2016).”
BackgroundHuman mini-blood–brain barrier models for biomedical neuroscience research: a review
Tran, M., Heo, C., Lee, L. P., & Cho, H. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00332-z · Cited by 34
Lee, S., Kim, H., Kim, B. S., Chae, S., Jung, S., Lee, J. S., Yu, J., Son, K., Chung, M., Kim, J. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44427-0 · Cited by 35
In vitro microvascular engineering approaches and strategies for interstitial tissue integration
Murphy, A. R., & Allenby, M. C. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.019 · Cited by 30
Exploring landscapes of brain morphogenesis with organoids
Jabaudon, D., & Lancaster, M. A. (2018) · Development · doi:10.1242/dev.172049 · Cited by 29
“Acknowledgements We thank James Briscoe and Pierre Vanderhaeghen, Chris Hughes and Mathias Lutolf for useful comments on the manuscript.”
BackgroundAn engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations
Moon, H., Özçelikkale, A., Yang, Y., Elzey, B. D., Konieczny, S. F., & Han, B. (2020) · Lab on a Chip · doi:10.1039/d0lc00707b · Cited by 29
Lung Organoid on a Chip: A New Ensemble Model for Preclinical Studies
Kim, H., Park, S., Jeong, S., Kim, J., & Cho, Y. (2023) · International Journal of Stem Cells · doi:10.15283/ijsc23090 · Cited by 31
“With cancer cell-derived organoids, the spheroid structure surrounded by microvessels had a similar shape and cellular density as in vivo models (34).”
A Vascularized Multilayer Chip Reveals Shear Stress-Induced Angiogenesis in Diverse Fluid Conditions
Yue, T., Yang, H. Y., Wang, Y., Jiang, N., Yin, H., Lu, X., Liu, N., & Xu, Y. (2025) · Cyborg and Bionic Systems · doi:10.34133/cbsystems.0207 · Cited by 34
“In the past works [ 30 , 31 ], it was possible to generate microvascular tissues in single-layer microfluidic chips by using biological self-assembly methods.”
Plug-and-Play In Vitro Metastasis System toward Recapitulating the Metastatic Cascade
Ni, B.-S., Tzao, C., & Huang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54711-z · Cited by 27
Trigt, W. K. V., Kelly, K. M., & Hughes, C. C. W. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.1006027 · Cited by 34
Self-citationExtrusion-Based Bioprinting: Current Standards and Relevancy for Human-Sized Tissue Fabrication
Willson, K., Ke, D., Kengla, C., Atala, A., & Murphy, S. V. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0520-2_5 · Cited by 33
Jongprasitkul, H., Turunen, S., Parihar, V. S., Annurakshita, S., & Kellomäki, M. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01322 · Cited by 27
Modeling 3D Human Tumor Lymphatic Vessel Network Using High‐Throughput Platform
Lee, S., Kang, H., Park, D., Yu, J., Koh, S. K., Cho, D., Kim, D., Kang, K., & Jeon, N. L. (2021) · Advanced Biology · doi:10.1002/adbi.202000195 · Cited by 33
On‐chip determination of tissue‐specific metastatic potential of breast cancer cells
Yildirir, B. F., Bati‐Ayaz, G., Tahmaz, İ., Bilgen, M., Pesen‐Okvur, D., & Yalcin-Ozuysal, Ö. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27855 · Cited by 34
“The permeability values for in vitro networks of endothelial cells or in vivo conditions (Dreher et al., 2006; Shirure et al., 2018; Sobrino et al., 2016; Yuan et al., 2009) are one or two orders of magnitude lower than those calculated for the EX‐chips in this study which are yet in agreement with previous studies us…”
ResultThe impact of pericytes on the stability of microvascular networks in response to nanoparticles
Dibble, M., Ciò, S. D., Luo, P., Balkwill, F. R., & Gautrot, J. E. (2023) · Scientific Reports · doi:10.1038/s41598-023-31352-x · Cited by 34
Quantitative Label‐Free Imaging of 3D Vascular Networks Self‐Assembled in Synthetic Hydrogels
Kaushik, G., Gil, D. A., Torr, E., Berge, E. S., Soref, C. M., Uhl, P., Fontana, G., Antosiewicz‐Bourget, J., Edington, C., Schwartz, M. P., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801186 · Cited by 26
Tackling rare diseases: Clinical trials on chips
Blumenrath, S. H., Lee, B. Y., Low, L. A., Prithviraj, R., & Tagle, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220924743 · Cited by 28
“Another study published in 2016 investigated the efficacy of chemotherapeutics in vascularized microtumors, such as breast and colorectal cancer.(19) In a collaborative effort, the Drug Information Association (DIA) and NIH-NCATS expanded this initial focus towards the development phase of therapeutics, convening two…”
BackgroundImaging therapeutic peptide transport across intestinal barriers
Larsen, J. B., Taebnia, N., Dolatshahi‐Pirouz, A., Eriksen, A. Z., Hjørringgaard, C. U., Kristensen, K., Larsen, N. W., Larsen, N. B., Marie, R., Mündler, A.-K., et al. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00024a · Cited by 28
Rajasekar, S., Lin, D. S. Y., Zhang, F., Sotra, A., Boshart, A., Clotet‐Freixas, S., Liu, A. W. K., Hirota, J. A., Ogawa, S., Konvalinka, A., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc01141c · Cited by 29
Laschke, M. W., Gu, Y. J., & Menger, M. D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.981161 · Cited by 27
Cell Culture Model Evolution and Its Impact on Improving Therapy Efficiency in Lung Cancer
Roman, V., Mihaila, M. A., Radu, N., Marineata, S., Diaconu, C. C., & Bostan, M. (2023) · Cancers · doi:10.3390/cancers15204996 · Cited by 28
“To overcome these limitations, the integration of 3D bioprinting with microfluidics was attempted, which enabled the fabrication of vascular channels [140].”
MethodTumor-on-a-chip platforms for assessing nanoparticle-based cancer therapy
Wang, Y., Cuzzucoli, F., Escobar, A., Lu, S., Liang, L., & Wang, S. (2018) · Nanotechnology · doi:10.1088/1361-6528/aac7a4 · Cited by 29
Metadata
- Authors
- Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 31589-31589
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4994029
- OpenAlex
- W2510834891
- Cited by
- 387
- References
- 58
- Citations by year
- 2026: 23 · 2025: 34 · 2024: 41 · 2023: 36 · 2022: 52 · 2021: 56 · 2020: 52 · 2019: 29 · 2018: 35 · 2017: 28 · 2016: 1
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Coordinating Council for Women in History
- National Institutes of Health (UH3TR000481, UL1TR001414, UH2TR000481)
- National Cancer Institute (R01CA170879, P30A062203, R01CA180122)
- National Center for Advancing Translational Sciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-on-a-chip, 3D extracellular matrix, colorectal cancer, breast cancer, tumor stroma, vascular targeting agents, VEGFR inhibitors, PDGFR inhibitors, metabolic heterogeneity, aerobic glycolysis, drug response
- MeSH terms
- Breast Neoplasms, Female, Humans, Male, Models, Biological, Neovascularization, Pathologic, Colorectal Neoplasms, Angiogenesis Inhibitors, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.